{"transactions":[{"id":961087,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:02.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124528/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985193,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:24.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116682/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033832,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:13.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090610/ownership.xml","form_type":"4"}},{"id":1330944,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:27.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109305/ownership.xml","form_type":"4"}},{"id":1368405,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T22:00:16.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024096887/ownership.xml","form_type":"4"}},{"id":1418833,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":false,"shares":2415,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.015,"exercise_date":"2017-04-14","expiration_date":"2024-04-14","underlying":"Common Stock","underlying_shares":2415},"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1418832,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":48,"price":0.75,"value":36.0,"ownership":{"direct":true},"balance_after":2367,"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1418831,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":true,"shares":2415,"price":0.015,"value":36.225,"ownership":{"direct":true},"balance_after":2415,"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1431464,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T20:06:41.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-070240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024070240/ownership.xml","form_type":"4"}},{"id":1761011,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T20:15:27.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001013762-23-003532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000101376223003532/ownership.xml","form_type":"4"}},{"id":2141073,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T20:06:56.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390022062476/ownership.xml","form_type":"4"}},{"id":2543199,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T21:25:21.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021052673/ownership.xml","form_type":"4"}},{"id":2624719,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T21:01:03.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021038692/ownership.xml","form_type":"4"}},{"id":2849082,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T21:07:37.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021010318/ownership.xml","form_type":"4"}},{"id":3009248,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T20:06:35.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020030790/ownership.xml","form_type":"4"}},{"id":3085477,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T20:08:14.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020017086/ownership.xml","form_type":"4"}},{"id":3394723,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T20:10:20.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390019020117/ownership.xml","form_type":"4"}},{"id":3823065,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2018-09-06T20:11:20.000Z","date":"2018-09-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019."}],"balance_after":15000,"derivative":{"exercise_price":1.62,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-18-012195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390018012195/ownership.xml","form_type":"4"}}]}